Cedar Mountain Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.9K | Hold |
81
| – | – | 0.01% | 124 |
|
|
2025
Q1 | $40.3K | Sell |
81
-2
| -2% | -$996 | 0.01% | 106 |
|
|
2024
Q4 | $43.2K | Sell |
83
-6
| -7% | -$3.12K | 0.01% | 98 |
|
|
2024
Q3 | $55.1K | Hold |
89
| – | – | 0.01% | 79 |
|
|
2024
Q2 | $49.2K | Hold |
89
| – | – | 0.01% | 73 |
|
|
2024
Q1 | $51.7K | Hold |
89
| – | – | 0.01% | 74 |
|
|
2023
Q4 | $47.2K | Buy |
89
+46
| +107% | +$24.4K | 0.01% | 75 |
|
|
2023
Q3 | $21.8K | Sell |
43
-11
| -20% | -$5.57K | 0.01% | 113 |
|
|
2023
Q2 | $28.2K | Hold |
54
| – | – | 0.01% | 102 |
|
|
2023
Q1 | $31.1K | Hold |
54
| – | – | 0.01% | 95 |
|
|
2022
Q4 | $29.7K | Hold |
54
| – | – | 0.01% | 96 |
|
|
2022
Q3 | $27K | Hold |
54
| – | – | 0.01% | 96 |
|
|
2022
Q2 | $29K | Hold |
54
| – | – | 0.01% | 94 |
|
|
2022
Q1 | $32K | Hold |
54
| – | – | 0.01% | 97 |
|
|
2021
Q4 | $36K | Hold |
54
| – | – | 0.01% | 90 |
|
|
2021
Q3 | $31K | Hold |
54
| – | – | 0.01% | 95 |
|
|
2021
Q2 | $27K | Hold |
54
| – | – | 0.01% | 100 |
|
|
2021
Q1 | $25K | Hold |
54
| – | – | 0.01% | 113 |
|
|
2020
Q4 | $25K | Hold |
54
| – | – | 0.01% | 109 |
|
|
2020
Q3 | $24K | Hold |
54
| – | – | 0.01% | 96 |
|
|
2020
Q2 | $20K | Buy |
54
+27
| +100% | +$10K | 0.01% | 102 |
|
|
2020
Q1 | $8K | Hold |
27
| – | – | ﹤0.01% | 139 |
|
|
2019
Q4 | $9K | Buy |
+27
| New | +$9K | ﹤0.01% | 143 |
|